The Researcher Spotlight: Innovations and advancements series highlights promising and innovative diabetes research and spotlights those leading the charge. Learn about Nestoras Mathioudakis, MD, MHS, and 2019 goals. Read More “Researcher Spotlight: Nestoras Mathioudakis, MD, MHS”
“Disease interception” introduces a paradigm shift in healthcare delivery, moving away from the standard model of ‘diagnose and treat’ to an innovative model of ‘predict and pre-empt.’ Dr Nicola Davies, PhD, explains how this new model applies to type 1 diabetes (T1D). Read More “Intercepting Type 1 Diabetes”
The Researcher Spotlight: Innovations and advancements series highlights promising and innovative diabetes research and spotlights those leading the charge. Learn about Mark Atkinson, PhD, and his 2019 goals. Read More “Researcher Spotlight: Mark Atkinson, PhD”
The Researcher Spotlight: Innovations and advancements series highlights promising and innovative diabetes research and spotlights those leading the charge. Read More “Researcher Spotlight: Innovation and Advancements”
“Alarmingly low” was the term used by authors of a new study that reported on the frequency of eye exams by people with diabetes. Read More “Study Finds Low Rates of Eye Exams in Diabetes Patients”
Research indicates that adding sulfonylureas to metformin or switching to sulfonylureas increases the risk of death and cardiovascular events. Read More “Adding Sulfonylureas to Metformin Can Be Dangerous”
The Researcher Spotlight: Innovations and advancements series highlights promising and innovative diabetes research and spotlights those leading the charge. Learn about Sylvia E. Rosas, MD, MSCE, and 2019 goals. Read More “Researcher Spotlight: Sylvia E. Rosas, MD, MSCE”
Health-care professionals must understand the specific care needs of seniors with diabetes, provide comprehensive monitoring and develop appropriate treatment regimens. Read More “Caring for Senior Adults with Type 2 Diabetes”
Researchers announced that they have discovered new information about HSL that might lead to the development of new drugs for Type 2 diabetes… Read More “Treating Type 2 Diabetes — A New Strategy”
Much revolution in thought has been driven over the last decade from knowledge gains resulting from studies involving JDRF’s nPOD program. Read More “Advances in Type 1 Diabetes Research Using Human Pancreas – Lessons from “nPOD””
